Many nutraceutical brands look at Australia for expansion. What they often don’t anticipate is how closely therapeutic claims are reviewed. If a product suggests health benefits, it may need to be included in the ARTG under the oversight of the Therapeutic Goods Administration (australia regulator).
Before launch, companies need clarity on classification, evidence, and listing requirements. Getting this wrong can slow everything down. In this article, we break down how nutraceuticals are classified and registered in Australia, including key regulatory considerations for businesses.
Nutraceutical Market Overview in Australia
Market value estimates place Australia’s nutraceutical sector in the multi-billion-dollar range, with moderate year-on-year growth rather than sharp spikes. Preventive health remains the main driver, particularly among ageing consumers. Sports nutrition and plant-based supplements have also expanded their share over the last few years.
Export demand, especially within Asia-Pacific, adds another commercial layer — largely due to confidence in Australian production standards.
Nutraceuticals Classification in Australia
Australia doesn’t legally recognise “nutraceutical” as a category. The term is used commercially, not in legislation. What matters is how the product is described. If it suggests a therapeutic benefit — even something like supporting joint health or reducing symptoms — it usually falls under the Therapeutic Goods Administration. That means it must be included in the ARTG, either as a listed or registered medicine.
If the product is presented simply as a food, without therapeutic intent, regulation shifts to Food Standards Australia New Zealand. In reality, the dividing line can be thin. A change in wording on a label can alter the entire regulatory pathway.
Nutraceutical Regulatory Guidelines in Australia
- Australia does not legally define “nutraceuticals”; products are assessed based on intended use and claims.
- Products making therapeutic claims are regulated as complementary medicines by the Therapeutic Goods Administration (TGA).
- Such products must be included in the Australian Register of Therapeutic Goods (ARTG) before supply.
- Depending on risk level, they are either Listed (AUST L) or Registered (AUST R).
- Only permitted ingredients can be used in listed complementary medicines.
- Sponsors are responsible for holding evidence that supports all indications and claims.
- Manufacturing must comply with Good Manufacturing Practice (GMP) standards.
- Labelling and advertising must follow TGA requirements and avoid misleading claims.
- Products positioned purely as foods, without therapeutic claims, fall under food standards regulated by Food Standards Australia New Zealand.
- Post-market monitoring applies, including adverse event reporting and compliance reviews.
Documents required for nutraceutical registration in Australia:
- Completed application submitted through the TGA electronic system
- Details of the Australian sponsor (local responsible entity)
- Full product formulation, including active and excipient ingredients
- Evidence supporting each claim or indication used on the label
- Manufacturing information, including site details and quality controls
- GMP clearance or certification for the manufacturing facility
- Finished product specifications and testing methods
- Stability data to justify the proposed shelf life
- Product labels, packaging artwork, and dosage instructions
- Risk management or pharmacovigilance arrangements (where applicable)
- Payment of applicable evaluation or listing fees
Registration Process for Nutraceuticals in Australia
Here is the step by step registration process for Nutraceuticals in Australia
1. Start with how the product is described
Before anything else, look at the claims. The wording on the label often decides whether the product sits under the Therapeutic Goods Administration framework and needs ARTG inclusion.
2. Check what’s inside the product
It’s not only about whether an ingredient is accepted; the quantity matters. Certain components have upper limits, and exceeding them can shift the product into a different regulatory category.
3. Decide the pathway
Lower-risk products usually follow the listed (AUST L) route. Higher-risk or higher-claim products move toward registration (AUST R), which involves deeper assessment.
4. Put the evidence in place
The sponsor must hold data that supports safety and the stated benefits. For registered products, this material is examined in detail.
5. Confirm manufacturing compliance
Production sites must meet recognised quality standards. Overseas facilities may require GMP clearance.
6. Prepare and lodge the application
Submission is made electronically, along with the required fee. Listed products are processed more quickly; registered ones undergo evaluation.
7. ARTG inclusion
Once accepted, the product receives an AUST L or AUST R number and can be supplied in Australia.
Nutraceutical Labelling and Advertising in Australia
In Australia, issues often arise not because of the product itself, but because of how it is described. Once a supplement is entered on the ARTG, the wording used on the label and in promotional material comes under scrutiny from the Therapeutic Goods Administration.
Claims need to stay within what is permitted for that type of product. Broad or exaggerated statements — especially those suggesting treatment of serious conditions — can attract attention quickly. Sponsors are expected to hold supporting evidence for the indications they use, even if that evidence is not submitted upfront for listed medicines.
Basic details must also be clear: active ingredients, dosage directions, warning statements, and the sponsor’s details. The same expectations extend beyond packaging to websites, social media posts, and digital campaigns.
Nutraceutical’s Timeline and fee associated
Timeline: It may take anywhere from 6 months to 2 years, depending on the complexity of the product and the quality of the evidence provided.
Fees: the fees for full registration ranged from approximately AUD 26,000 to AUD 115,000, depending on the risk level and complexity of the application.
Conclusion
Australia can be an attractive market for nutraceutical products, but the regulatory expectations are clear and closely followed. Products that are well-positioned and properly supported tend to move forward without difficulty. Those that overlook classification or claim boundaries often face delays. Preparation, in this context, matters more than speed.
Our Nutraceutical Regulatory Professionals assist companies with Australian market entry planning, submission management, GMP coordination, and post-market support under the Therapeutic Goods Administration. We aim to provide practical regulatory guidance that keeps projects on track without unnecessary complexity.
Contact us at info@artixio.com!
